Page last updated: 2024-11-11

eniporide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

eniporide: inhibits NHE-1 isoform; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6433092
CHEMBL ID64360
SCHEMBL ID6619621
MeSH IDM0383182

Synonyms (36)

Synonym
eniporide [inn]
emd-96785
eniporide
CHEMBL64360 ,
bdbm50058715
n-(5-methanesulfonyl-2-methyl-4-pyrrol-1-yl-benzoyl)-guanidine (eniporide, emd-96-875)
n-(5-methanesulfonyl-2-methyl-4-pyrrol-1-yl-benzoyl)-guanidine
n-(diaminomethylene)-2-methyl-5-(methylsulfonyl)-4-(1h-pyrrol-1-yl)benzamide
n-(diaminomethylidene)-2-methyl-5-methylsulfonyl-4-pyrrol-1-ylbenzamide
unii-7igf9182qu
n-(diaminomethylene)-5-(methylsulfonyl)-4-pyrrol-1-yl-o-toluamide
176644-21-6
7igf9182qu ,
AKOS016007503
emd 96785
SCHEMBL6619621
n-diaminomethylene-2-methyl- 4-(1-pyrrolyl)-5-methylsulfonylbenzamide
n-diaminomethylene-2-methyl-4-(1-pyrrolyl)-5-methylsulfonylbenzamide
UADMBZFZZOBWBB-UHFFFAOYSA-N
eniporide [who-dd]
AKOS024262733
n-carbamimidoyl-2-methyl-5-(methylsulfonyl)-4-(1h-pyrrol-1-yl)benzamide
mfcd08690425
2-methyl-5-methylsulfonyl-4-(1-pyrrolyl)-benzoylguanidine
eniporide(emd96785)
DTXSID30870132
EX-A1476
DS-16493
BCP09780
A14139
Q27268348
SB62053
BHA64421
AC-36852
CS-0024990
HY-106150

Research Excerpts

Overview

Eniporide (EMD 96 875) is a novel and selective inhibitor of the Na+-H+ exchange (NHE-1) inhibitor.

ExcerptReferenceRelevance
"Eniporide (EMD 96 875) is a novel and selective inhibitor of the Na+-H+ exchange (NHE-1) inhibitor. "( Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction.
Bhattaram, VA; Derendorf, H; Kovar, A; Kroesser, S; Machnig, T; Nagaraja, NV; Peters, T, 2005
)
2.06

Treatment

ExcerptReferenceRelevance
"untreated) and eniporide (p < 0.01 vs."( Na+ overload during ischemia and reperfusion in rat hearts: comparison of the Na+/H+ exchange blockers EIPA, cariporide and eniporide.
ten Hove, M; van Echteld, CJ; van Emous, JG, 2003
)
0.87

Pharmacokinetics

ExcerptReferenceRelevance
" Concentrations of parent drug and its metabolite were measured by HPLC, and the data were analyzed by noncompartmental and compartmental pharmacokinetic methods."( Pharmacokinetic/pharmacodynamic evaluation of the NHE inhibitor eniporide.
Beier, N; Derendorf, H; Kovar, A; Peters, T, 2001
)
0.55
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" In addition, the gem-dimethyl series of analogues seem to display improved oral bioavailability and longer plasma half-life in rats."( Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
Ahmad, S; Atwal, KS; Chen, AY; Chen, BC; DiMarco, JD; Dorso, CR; Doweyko, LM; Dugar, S; Gavin, BJ; Gougoutas, JZ; Grazier, N; Kirby, M; Lan, SJ; Ngu, K; Serafino, R; Wu, SC; Yost, KJ, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" The impact of the covariates on eniporide pharmacokinetics is minimal to warrant any dosage adjustments in patient population."( Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction.
Bhattaram, VA; Derendorf, H; Kovar, A; Kroesser, S; Machnig, T; Nagaraja, NV; Peters, T, 2005
)
0.9
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium/hydrogen exchanger 1Homo sapiens (human)IC50 (µMol)0.15580.00500.56013.5000AID1341120; AID1341847; AID1411094; AID143805; AID143806; AID270790
Sodium/hydrogen exchanger 1Oryctolagus cuniculus (rabbit)IC50 (µMol)0.00800.00800.01760.0260AID167716; AID205451
Sodium/hydrogen exchanger 3Oryctolagus cuniculus (rabbit)IC50 (µMol)0.00800.00800.01700.0260AID167716; AID205451
Sodium/hydrogen exchanger 3Homo sapiens (human)IC50 (µMol)82.50000.00050.00350.0050AID1341122; AID1341853; AID1411099; AID143809
Sodium/hydrogen exchanger 2Oryctolagus cuniculus (rabbit)IC50 (µMol)0.00800.00800.26131.0000AID167716; AID205451
Sodium/hydrogen exchanger 5Homo sapiens (human)IC50 (µMol)30.00000.42000.42000.4200AID1341117; AID1341852; AID1411100; AID143810
Sodium/hydrogen exchanger 2Homo sapiens (human)IC50 (µMol)8.20002.00004.01439.2000AID1341121; AID1341850; AID1411095; AID143807; AID143808; AID270791
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (43)

Processvia Protein(s)Taxonomy
monoatomic ion transportSodium/hydrogen exchanger 1Homo sapiens (human)
intracellular sodium ion homeostasisSodium/hydrogen exchanger 1Homo sapiens (human)
regulation of pHSodium/hydrogen exchanger 1Homo sapiens (human)
response to acidic pHSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of cardiac muscle hypertrophySodium/hydrogen exchanger 1Homo sapiens (human)
regulation of cardiac muscle contraction by calcium ion signalingSodium/hydrogen exchanger 1Homo sapiens (human)
cell migrationSodium/hydrogen exchanger 1Homo sapiens (human)
maintenance of cell polaritySodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of cell growthSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to insulin stimulusSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilitySodium/hydrogen exchanger 1Homo sapiens (human)
response to muscle stretchSodium/hydrogen exchanger 1Homo sapiens (human)
sodium ion export across plasma membraneSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of apoptotic processSodium/hydrogen exchanger 1Homo sapiens (human)
negative regulation of apoptotic processSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of action potentialSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISodium/hydrogen exchanger 1Homo sapiens (human)
stem cell differentiationSodium/hydrogen exchanger 1Homo sapiens (human)
protein complex oligomerizationSodium/hydrogen exchanger 1Homo sapiens (human)
regulation of intracellular pHSodium/hydrogen exchanger 1Homo sapiens (human)
regulation of stress fiber assemblySodium/hydrogen exchanger 1Homo sapiens (human)
regulation of focal adhesion assemblySodium/hydrogen exchanger 1Homo sapiens (human)
cardiac muscle cell differentiationSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to coldSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of calcineurin-NFAT signaling cascadeSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to antibioticSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to electrical stimulusSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to mechanical stimulusSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to organic cyclic compoundSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to hypoxiaSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to acidic pHSodium/hydrogen exchanger 1Homo sapiens (human)
cellular response to epinephrine stimulusSodium/hydrogen exchanger 1Homo sapiens (human)
cardiac muscle cell contractionSodium/hydrogen exchanger 1Homo sapiens (human)
regulation of cardiac muscle cell membrane potentialSodium/hydrogen exchanger 1Homo sapiens (human)
regulation of the force of heart contraction by cardiac conductionSodium/hydrogen exchanger 1Homo sapiens (human)
sodium ion import across plasma membraneSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of the force of heart contractionSodium/hydrogen exchanger 1Homo sapiens (human)
proton transmembrane transportSodium/hydrogen exchanger 1Homo sapiens (human)
positive regulation of calcium:sodium antiporter activitySodium/hydrogen exchanger 1Homo sapiens (human)
potassium ion transmembrane transportSodium/hydrogen exchanger 1Homo sapiens (human)
monoatomic ion transportSodium/hydrogen exchanger 3Homo sapiens (human)
regulation of intracellular pHSodium/hydrogen exchanger 3Homo sapiens (human)
sodium ion import across plasma membraneSodium/hydrogen exchanger 3Homo sapiens (human)
proton transmembrane transportSodium/hydrogen exchanger 3Homo sapiens (human)
potassium ion transmembrane transportSodium/hydrogen exchanger 3Homo sapiens (human)
monoatomic ion transportSodium/hydrogen exchanger 5Homo sapiens (human)
sodium ion transmembrane transportSodium/hydrogen exchanger 5Homo sapiens (human)
regulation of intracellular pHSodium/hydrogen exchanger 5Homo sapiens (human)
proton transmembrane transportSodium/hydrogen exchanger 5Homo sapiens (human)
potassium ion transmembrane transportSodium/hydrogen exchanger 5Homo sapiens (human)
sodium ion import across plasma membraneSodium/hydrogen exchanger 5Homo sapiens (human)
monoatomic ion transportSodium/hydrogen exchanger 2Homo sapiens (human)
protein localizationSodium/hydrogen exchanger 2Homo sapiens (human)
epithelial cell differentiationSodium/hydrogen exchanger 2Homo sapiens (human)
proton transmembrane transportSodium/hydrogen exchanger 2Homo sapiens (human)
sodium ion import across plasma membraneSodium/hydrogen exchanger 2Homo sapiens (human)
potassium ion transmembrane transportSodium/hydrogen exchanger 2Homo sapiens (human)
regulation of intracellular pHSodium/hydrogen exchanger 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
protein bindingSodium/hydrogen exchanger 1Homo sapiens (human)
calmodulin bindingSodium/hydrogen exchanger 1Homo sapiens (human)
phospholipid bindingSodium/hydrogen exchanger 1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingSodium/hydrogen exchanger 1Homo sapiens (human)
sodium:proton antiporter activitySodium/hydrogen exchanger 1Homo sapiens (human)
protein phosphatase 2B bindingSodium/hydrogen exchanger 1Homo sapiens (human)
protein-macromolecule adaptor activitySodium/hydrogen exchanger 1Homo sapiens (human)
identical protein bindingSodium/hydrogen exchanger 1Homo sapiens (human)
calcium-dependent protein bindingSodium/hydrogen exchanger 1Homo sapiens (human)
molecular adaptor activitySodium/hydrogen exchanger 1Homo sapiens (human)
sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potentialSodium/hydrogen exchanger 1Homo sapiens (human)
potassium:proton antiporter activitySodium/hydrogen exchanger 1Homo sapiens (human)
protein bindingSodium/hydrogen exchanger 3Homo sapiens (human)
sodium:proton antiporter activitySodium/hydrogen exchanger 3Homo sapiens (human)
PDZ domain bindingSodium/hydrogen exchanger 3Homo sapiens (human)
phosphatidylinositol bindingSodium/hydrogen exchanger 3Homo sapiens (human)
identical protein bindingSodium/hydrogen exchanger 3Homo sapiens (human)
potassium:proton antiporter activitySodium/hydrogen exchanger 3Homo sapiens (human)
protein bindingSodium/hydrogen exchanger 5Homo sapiens (human)
sodium:proton antiporter activitySodium/hydrogen exchanger 5Homo sapiens (human)
arrestin family protein bindingSodium/hydrogen exchanger 5Homo sapiens (human)
potassium:proton antiporter activitySodium/hydrogen exchanger 5Homo sapiens (human)
sodium:proton antiporter activitySodium/hydrogen exchanger 2Homo sapiens (human)
potassium:proton antiporter activitySodium/hydrogen exchanger 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
nucleoplasmSodium/hydrogen exchanger 1Homo sapiens (human)
cytoplasmSodium/hydrogen exchanger 1Homo sapiens (human)
mitochondrionSodium/hydrogen exchanger 1Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 1Homo sapiens (human)
focal adhesionSodium/hydrogen exchanger 1Homo sapiens (human)
cell surfaceSodium/hydrogen exchanger 1Homo sapiens (human)
intercalated discSodium/hydrogen exchanger 1Homo sapiens (human)
membraneSodium/hydrogen exchanger 1Homo sapiens (human)
basolateral plasma membraneSodium/hydrogen exchanger 1Homo sapiens (human)
apical plasma membraneSodium/hydrogen exchanger 1Homo sapiens (human)
lamellipodiumSodium/hydrogen exchanger 1Homo sapiens (human)
T-tubuleSodium/hydrogen exchanger 1Homo sapiens (human)
membrane raftSodium/hydrogen exchanger 1Homo sapiens (human)
perinuclear region of cytoplasmSodium/hydrogen exchanger 1Homo sapiens (human)
extracellular exosomeSodium/hydrogen exchanger 1Homo sapiens (human)
cation-transporting ATPase complexSodium/hydrogen exchanger 1Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 1Homo sapiens (human)
early endosomeSodium/hydrogen exchanger 3Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 3Homo sapiens (human)
brush borderSodium/hydrogen exchanger 3Homo sapiens (human)
cell surfaceSodium/hydrogen exchanger 3Homo sapiens (human)
apical plasma membraneSodium/hydrogen exchanger 3Homo sapiens (human)
brush border membraneSodium/hydrogen exchanger 3Homo sapiens (human)
early endosome membraneSodium/hydrogen exchanger 3Homo sapiens (human)
recycling endosome membraneSodium/hydrogen exchanger 3Homo sapiens (human)
extracellular exosomeSodium/hydrogen exchanger 3Homo sapiens (human)
apical plasma membraneSodium/hydrogen exchanger 3Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 3Homo sapiens (human)
brush border membraneSodium/hydrogen exchanger 3Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 5Homo sapiens (human)
focal adhesionSodium/hydrogen exchanger 5Homo sapiens (human)
membraneSodium/hydrogen exchanger 5Homo sapiens (human)
dendritic spine membraneSodium/hydrogen exchanger 5Homo sapiens (human)
neuron spineSodium/hydrogen exchanger 5Homo sapiens (human)
synapseSodium/hydrogen exchanger 5Homo sapiens (human)
postsynaptic membraneSodium/hydrogen exchanger 5Homo sapiens (human)
recycling endosome membraneSodium/hydrogen exchanger 5Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 5Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 2Homo sapiens (human)
membraneSodium/hydrogen exchanger 2Homo sapiens (human)
apical plasma membraneSodium/hydrogen exchanger 2Homo sapiens (human)
plasma membraneSodium/hydrogen exchanger 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID701662Oral bioavailability in jugular and femoral vein precannulated Sprague-Dawley rat plasma at 5 mg/kg by LC/MS/MS analysis2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.
AID143806In vitro concentration required to inhibit NHE-1 mediated intracellular maximal pH recovery by 50%2001Bioorganic & medicinal chemistry letters, Mar-26, Volume: 11, Issue:6
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility.
AID270792Selectivity for human NHE1 over NHE22006Bioorganic & medicinal chemistry letters, Sep-15, Volume: 16, Issue:18
Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
AID232710Selectivity ratio of NHE-1 verus NHE-2 was determined2001Bioorganic & medicinal chemistry letters, Mar-26, Volume: 11, Issue:6
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID93158Concentration to achieve half-maximal inhibition of acid-induced swelling in human platelets using platelet swelling assay1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
Bicyclic acylguanidine Na+/H+ antiporter inhibitors.
AID701663Volume of distribution at steady state in jugular and femoral vein precannulated Sprague-Dawley rat at 1 mg/kg, iv by LC/MS/MS analysis2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.
AID167716Inhibition of 5-N-(ethyl isopropyl)-amiloride[EIPA]-sensitive Na+ uptake into acidified rabbit erythrocytes.1997Journal of medicinal chemistry, Jun-20, Volume: 40, Issue:13
(2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors.
AID701664Mean resident time in jugular and femoral vein precannulated Sprague-Dawley rat at 1 mg/kg, iv by LC/MS/MS analysis2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.
AID143810Compound is screened in AP1 cells expressing human NHE-5 for sodium hydrogen exchange activity2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
AID143807Compound is screened in AP1 cells expressing human NHE-2 for sodium hydrogen exchange activity2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
AID143808In vitro concentration of compound required to inhibit NHE-2 mediated intracellular maximal pH recovery by 50%2001Bioorganic & medicinal chemistry letters, Mar-26, Volume: 11, Issue:6
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility.
AID270790Inhibition of human NHE1 expressed in Ap1 cell line2006Bioorganic & medicinal chemistry letters, Sep-15, Volume: 16, Issue:18
Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
AID205451Sodium/hydrogen exchanger antiport activity was measured using [22]Na+ uptake inhibition assay in acidified rabbit erythrocytes1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
Bicyclic acylguanidine Na+/H+ antiporter inhibitors.
AID701665Clearance in jugular and femoral vein precannulated Sprague-Dawley rat at 1 mg/kg, iv by LC/MS/MS analysis relative to hepatic blood flow2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID143805Screened in AP1 cells expressing human NHE-1 for sodium hydrogen exchange activity2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
AID270791Inhibition of human NHE2 expressed in Ap1 cell line2006Bioorganic & medicinal chemistry letters, Sep-15, Volume: 16, Issue:18
Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID143809Compound is screened in AP1 cells expressing human NHE-3 for sodium hydrogen exchange activity2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (9.68)18.2507
2000's26 (83.87)29.6817
2010's2 (6.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.63 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (9.38%)5.53%
Reviews2 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (84.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]